A Novel Method to Detect Lymphangioleiomyomatosis (LAM) Using CNN- LSTM on Computed Tomography
Authors/Creators
- 1. Department of Computer Science and Engineering, Kalaignarkarunanidhi Institute of Technology Coimbatore (Tamil Nadu), India.
- 1. Department of Computer Science and Engineering, Kalaignarkarunanidhi Institute of Technology Coimbatore (Tamil Nadu), India.
- 2. Assistant Professor, Kalaignarkarunanidhi Institute of Technology Coimbatore (Tamil Nadu), India.
Description
Abstract: “Detection of Lymphangioleiomyomatosis (LAM) using CNN-LSTM framework on CT images”, Lymphangioleiomyomatosis (LAM) is a progressive lung disease marked by uncommon cystic growths, often diagnosed using high-resolution CT scan images. The complex nature of LAM's radiological findings and the need for specialized knowledge make early and correct diagnosis difficult, even though it is essential for successful treatment. In order to automate the detection of LAM in CT images, this study introduces an advanced deep learning approach that integrates CNN with LSTM networks. A well-annotated dataset of CT scans from patients with LAM and healthy controls was used to create and evaluate the model. To increase model robustness and generalizability, extensive preprocessing was used, including lung area segmentation and data augmentation. Accuracy, sensitivity, specificity, and AUC-ROC were among the key performance indicators that demonstrated how well the model distinguished between LAM and non-LAM cases. The accuracy of the CNN-LSTM model for detecting Lymphangioleiomyomatosis (LAM) using CT scan images is approximately 80%. By providing a dependable, non-invasive, and scalable approach to early LAM identification, this novel CNN-LSTM design lessens the need for expert interpretation and improves diagnostic effectiveness.
Files
B105205020125.pdf
Files
(479.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:dc6041c952bda5148b6d631f073df99f
|
479.0 kB | Preview Download |
Additional details
Identifiers
- EISSN
- 2582-7588
- DOI
- 10.54105/ijpmh.B1052.05011124
Dates
- Accepted
-
2024-11-15Manuscript received on 29 October 2024 | Revised Manuscript received on 05 November 2024 | Manuscript Accepted on 15 November 2024 | Manuscript published on 30 November 2024.
References
- Alexa. E,Chloe Steveson,"Ultra low dose CT with Silver filter and deep learning reconstruction significantly reduces radiation and retain quantitative information in the investigation and monitoring of Lymphangioleiomyomatosis" European Radiology [2024]. DOI: https://doi.org/10.1007/s00330-024-10649-z
- Anushka K palipana, Emra Gecili," Predicting Indualized lung disease progression in treatment naïve patient with Lymphangioleiomyomatosis(LAM)" Epub [2023]. DOI: https://doi.org/10.1016/j.chest.2022.12.027
- Eileen Wang-koheler ,Adina.R "Complications of lymphangioleiomyomatosis(LAM) in pregnancy" Elsevier [2024]. DOI: https://doi.org/10.1016/j.xagr.2024.100309
- Xiang jia,Chen Qiantong , "Study on diffuse cystic lung disease based on deep learning."Journal of Science direct[2024]. https://openurl.ebsco.com/EPDB%3Agcd%3A14%3A2656526/detailv 2?sid=ebsco%3Aplink%3Ascholar&id=ebsco%3Agcd%3A180445423 &crl=c&link_origin=scholar.google.co.in
- Eun Min lee, Ju hee kim"Uterine lymphangioleiomyomatosis (LAM) in a premenopausal woman with tuberous sclerosis"Elsevier[2024]. DOI: https://doi.org/10.1016/j.crwh.2024.e00650
- Claire.E, Lawrence .A "Unsupervised Exercise in Interstital Lung Disease"CHEST journal [2024]. https://journal.chestnet.org/action/showPdf?pii=S0012- 3692%2824%2904613-0
- David rudilla, Maria Molina,"A study on the Psychological profile and coping with the disease in patients with Lymphangioleiomyomatosis(LAM)", Elsevier[2024]. DOI: https://doi.org/10.1016/j.opresp.2024.100327
- Kundu .N, Holz MK "Lymphangioleiomyomatosis (LAM): a metastanic lung disease"AM J physiol cell [2023]. DOI: https://doi.org/10.1152/ajpcell.00202.2022
- McCormack FX, Inoue Y "Efcacy and safety of sirolimus LAM"[2011]. DOI: https://doi.org/10.1056/NEJMoa1100391
- Rudilla D, Beceiro MJ, Alonso T, Oliver A, Soriano J, Valenzuela C, et al. Psychological profile of patients diagnosed with idiopathic pulmonary fibrosis. Arch Bronconeumol. 2022;58:191– 3, http://dx.doi.org/10.1016/j.arbres.2021.04.025
- Yeom JA, Kim KU, Hwang M et al (2022) Emphysema quantifcation using ultra-low-dose chest CT: efcacy of deep learning-based image recon- struction. Medicina (Kaunas) 58:939. DOI: https://doi.org/10.3390/medicina58070939
- Pouw T, de Man-van Ginkel J, Hardeman JA, Mager JJ, Trapman L, Jaarsma T, et al. The association of resilience with self-care and quality of life in people with chronic obstructive pulmonary disease: a crosssectional study. Nurs Open. 2023;10:7738–48, http://dx.doi.org/10.1002/nop2.2015
- Pollok J, van Agteren JE, Esterman AJ, Carson- Chahhoud KV. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019;3:CD012347, http://dx.doi.org/10.1002/14651858.CD012347.pub2
- Araujo MS, Baldi BG, Freitas CS, Albuquerque AL, Marques da Silva CC, Kairalla RA, et al. Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial. Eur Respir J. 2016. DOI: https://doi.org/10.1183/13993003.01683-2015
- Cottin V, Archer F, Leroux C, Mornex JF, Cordier JF. Milestones in lymphangioleiomyomatosis research. Eur Respir Rev. 2011;20:3–6, http://dx.doi.org/10.1183/09059180.00000311